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Abstract 
Purpose: Hand‑held vital microscopes (HVMs) were introduced to observe sublingual microcirculatory alterations at 
the bedside in different shock states in critically ill patients. This consensus aims to provide clinicians with guidelines 
for practical use and interpretation of the sublingual microcirculation. Furthermore, it aims to promote the integration 
of routine application of HVM microcirculatory monitoring in conventional hemodynamic monitoring of systemic 
hemodynamic variables.
Methods: In accordance with the Delphi method we organized three international expert meetings to discuss the 
various aspects of the technology, physiology, measurements, and clinical utility of HVM sublingual microcirculatory 
monitoring to formulate this consensus document. A task force from the Cardiovascular Dynamics Section of the 
European Society of Intensive Care Medicine (with endorsement of its Executive Committee) created this consensus 
as an update of a previous consensus in 2007. We classified consensus statements as definitions, requirements, and/or 
recommendations, with a minimum requirement of 80% agreement of all participants.
Results: In this consensus the nature of microcirculatory alterations is described. The nature of variables, which can 
be extracted from analysis of microcirculatory images, is presented and the needed dataset of variables to identify 
microcirculatory alterations is defined. Practical aspects of sublingual HVM measurements and the nature of artifacts 
are described. Eleven statements were formulated that pertained to image acquisitions and quality statements. Four‑
teen statements addressed the analysis of the images, and 13 statements are related to future developments.
Conclusion: This consensus describes 25 statements regarding the acquisition and interpretation of microcirculatory 
images needed to guide the assessment of the microcirculation in critically ill patients.
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Introduction
A large body of evidence on the presence of microcircu-
latory alterations in critically ill patients has come to light 
since the clinical introduction of hand-held vital micro-
scopes (HVMs) in the late 1990s. This evidence has led to 
the need to formulate an update of a consensus on sub-
lingual microcirculatory imaging as applied at the bed-
side. The first applications of HVM were accomplished 
by the introduction of the first generation of HVM called 
orthogonal polarization spectral (OPS) imaging dur-
ing neurosurgery [1, 2]. Consequently, this led the way 
to the measurement of microcirculatory alterations in 
critically ill patients at the bedside where De Backer and 
co-workers reported that persistent microcirculatory 
alterations in patients with septic shock were associated 
with increased mortality, independent of alterations of 
the systemic macrocirculation [3]. Spronk and co-work-
ers demonstrated that nitroglycerine therapy following 
pressure-guided resuscitation improved microcircula-
tory flow in patients with septic shock [4]. Soon after, an 
increasing number of manuscripts using HVM were 
published, the majority of which concerned critically ill 
patients. From the results it became clear that microcir-
culatory alterations were significantly correlated with 
the progress of human sepsis and predictive of organ 
failure and mortality [5–10]. Although most microcir-
culatory measurements using HVM were carried out in 
the sublingual area, several investigations of the micro-
circulation were carried out directly on organ surfaces 
during surgery [2, 11–15]. Indeed, sublingual microcir-
culatory alterations have been identified using HVM in a 
wide range of disease states other than sepsis and shock 
[16–26] and in different age groups including critically 
ill newborns [27]. In 2009, an international multicenter 
observational prevalence study in intensive care patients 
involving 36 ICUs worldwide enrolling 501 patients iden-
tified microcirculatory alterations (microvascular flow 
index, MFI < 2.6) in combination with tachycardia (heart 
rate >  90) as an independent risk factor for increased 
hospital mortality [28]. Various studies have been under-
taken to define normal values in adults, newborns, and 
neonates [29–33], as well as in healthy individuals under 
extreme environmental conditions [34, 35]. In studies 
where systemic hemodynamic monitoring was being 
applied, it became increasingly clear that microcircula-
tory alterations can occur independently from systemic 
hemodynamic alterations and that these microcirculatory 
alterations were independently associated with adverse 
clinical outcome [6–8]. However, the practical applica-
tion of microcirculatory measurement using HVM and 
the interpretation of the images of these measurements 
remain challenging.
Technical developments of HVM helped in making 
the measurement of the microcirculation increasingly 
feasible. The technical issue that had to be overcome in 
the application of HVM for studying the microcircula-
tion on organ surfaces was the need for an optical system 
to be developed, where illumination and observation of 
the microcirculation beneath the surface of an organ are 
accomplished through the same optical pathway embed-
ded in a light guide with a magnification lens attached to 
its end.
The first generation of such HVM devices which solved 
this problem was based on orthogonally polarized spec-
tral (OPS) imaging [1, 36], where an externally filtered 
light source illuminated the organ surface with linearly 
polarized light, and reflected light was blocked by an 
orthogonally polarized analyzer. Although these first-
generation HVM devices pioneered the initial studies, 
they are no longer commercially available. The second 
generation was based on sidestream dark-field (SDF) 
imaging, whereby illumination was achieved by sur-
rounding the tip of the light guide with light-emitting 
diodes creating dark-field illumination [37]. Recently, a 
third-generation device was introduced which is based 
on an alternative mode of dark-field microscopy called 
incident dark-field (IDF) imaging [38] with improved 
optical resolution which gave better image quality and 
allowed for the visualization of more capillaries than 
previous-generation devices [39–42]. The last two tech-
niques are currently commercially available. Massey and 
Shapiro wrote an excellent comprehensive review of the 
technical aspects of HVM [43]. Table 1 summarizes the 
different technical properties of the currently available 
HVM devices obtained from this publication.
An important reason to evaluate the functional state 
of the microcirculation in conditions of shock and resus-
citation is to verify the expectation that correction of 
systemic hemodynamic variables results in a parallel 
improvement in tissue perfusion, a condition referred to 
as hemodynamic coherence [44]. However, uncertainty 
remains when correction of systemic hemodynamic vari-
ables has been achieved, but downstream variables used 
as surrogates for tissue hypoperfusion, such as lactate, 
mottling skin, oliguria, and cold extremities, remain 
unaltered and abnormal. This can occur as a consequence 
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of the nature of the disease or due to an ineffective ther-
apy such fluids [45, 46] or vasopressors not being effec-
tive in improving the microcirculation [47–49]. Such a 
loss of coherence between the macro- and microcircu-
lation has been described in several clinical and experi-
mental studies [8, 23, 44, 48–52] and has been found to 
be an independent predictor of adverse outcome and 
organ dysfunction [6–10]. Its manifestation, however, is a 
dynamic process depending on the interactions between 
disease, therapy, and time. Figure 1 summarizes four con-
ditions in which this loss of hemodynamic coherence 
occurs and microcirculatory alterations persist despite 
optimization of systemic hemodynamic variables [44]. 
Monitoring the microcirculation during resuscitation 
procedures can then verify whether they have been effec-
tive in restoring tissue perfusion to some minimal value, 
which is the ultimate expected result of resuscitation 
procedures. Observation of the type of microcirculatory 
alterations can unveil information about the mechanisms 
causing shock and help to determine an appropriate ther-
apeutic response [46].
A consensus was published in 2007 by a group of 
experts to discuss the various technical, physiological, 
and clinical aspects of microcirculatory monitoring. The 
resulting consensus paper described the conditions that 
needed to be met for image acquisition and consolidated 
the various scoring methodologies being developed at the 
time [53]. These methodologies related to the descrip-
tion of functional variables obtained from analysis of the 
HVM-derived microcirculatory images. Some 10  years 
later more than 600 articles about clinical and experi-
mental investigations using HVM have been published. 
Together with current developments in the technology 
of HVM by introduction of a third-generation computer-
controlled image sensor-based HVM with improved 
optics, it became clear that the definitions in the previous 
consensus had to be adapted and that it was necessary to 
organize an updated second consensus on the state of the 
art of HVM and its application in intensive care medi-
cine. Table  2 summarizes the main differences between 
the previous Critical Care 2007 consensus paper and the 
current Intensive Care Medicine 2018 consensus arti-
cle, which comprises image quality, analysis, and future 
perspectives.
Methods
This paper reflects the current state of the art of moni-
toring of the (sublingual) microcirculation and describes 
the consensus reached on the requirements for ensur-
ing good quality measurements, as well as the analysis 
for obtaining variables reflecting the functional status 
of the microcirculation by the experts listed as authors. 
Since HVM measurements are predominantly performed 
in the sublingual area, we will restrict ourselves to the 
methodology in this particular vascular bed. The present 
paper was endorsed by the Executive Committee of the 
European Society of Intensive Care Medicine (ESICM) as 
an expert opinion guideline for microcirculation moni-
toring in 2017. The intended format of this paper has 
been taken from previous expert opinion papers, e.g., 
the guideline on circulatory shock and hemodynamic 
monitoring [54] and the position paper on hemodynamic 
monitoring [55]. We addressed five questions regarding 
the methodology and interpretation of microcirculatory 
alterations using HVM: (1) What has been the develop-
ment of the technology since the last consensus of 2007? 
Table 1 Comparison between SDF/IDF technical specifications (adapted from Massey and Shapiro [53] with permission)
SDF sidestream dark-field (imaging), IDF incident dark-field (imaging), NTSC national television system committee, PAL phase altering line
a Capiscope HVCS-HR uses the same camera, illumination, and optics as the Capiscope HVCS, with a modified sensor and electronics
b Measured using an NTSC version and Canopus ADVC110 video digitizer
c  Measured using a 150 line-pairs per inch Ronchi ruling (Edmund Optics, Barrington, NJ, USA)
d Private communication with manufacture
Microscan (Microvision 
Medical, Amsterdam, Neth-
erlands)
Capiscope HVCS (KK tech-
nology, Honiton, UK)
Capiscope HVCS-HRa (KK 
technology, Honiton, UK)
Cytocam (Braedius Medical, 
Huizen, Netherlands)
Type SDF SDF SDF IDF
Image size (pixels) NTSC: 720 × 480 752 × 480 1280 × 1024 2208 × 1648
PAL: 720 × 576
Resolution (μm/pixel) 1.45 (horizontal) 0.92 0.81 0.66c
1.55 (vertical)b
Field of view (μm) 1044 × 758 (NTSC) 692 × 442 1037 × 829 1457 × 1061
Frame rate (frames/s) NTSC: 30 Up  87d 25d 25
PAL: 25
Illumination time (ms) 10 0.5–2d 0.5–2d 2
Fig. 1 Microcirculatory alterations associated with loss hemodynamic coherence. States of loss of hemodynamic coherence where macrocircula‑
tory resuscitation does not necessarily cause a parallel improvement in the perfusion of the microcirculation. Type 1: Heterogeneous red blood cell 
(RBC) flow where flowing RBCs carry oxygen (red RBC) and stagnant RBC (dark red); correspondingly, tissue cells receive oxygen (red tissue cells) or 
not (blue tissue cells). Type 2: A reduction in the oxygen‑carrying capacity of the microcirculation due to hemodilution. Type 3: A stagnation in RBC 
flow in the microcirculation due to arterial vasoconstriction (increased vascular resistance, R) and/or raised venous pressures (P). Type 4: Increased 
oxygen diffusion distances due to edema. (Adapted from [44])
(2) What are the differences between the current consen-
sus and the previous consensus? (3) What are the cur-
rent definitions and what quality of measurements and 
recommendations are needed to perform reliable sublin-
gual measurements? (4) What microcirculatory variables 
best reflect the functional state of the microcirculation? 
(5) What recommendations are given for future improve-
ment of the technology for introducing HVM as a stand-
ard bedside hemodynamic monitoring tool for clinical 
decision-making?
To arrive at this consensus we organized three interna-
tional meetings in accordance with the Delphi method, 
where an agreement of more than 80% of the authors of 
the present paper on the statements (definitions, require-
ments, and recommendations) listed in the tables was 
considered as being a consensus [54]. During the first 
meeting (Amsterdam, November 20th 2015) all partici-
pants identified the issues including the various aspects 
of the technology, physiology, measurements, and clini-
cal utility of the current consensus document. During the 
second meeting (Brussels March 16th 2016) these top-
ics were structured into three categories: image acquisi-
tion and quality, image analysis, and future perspectives. 
In the wake of this meeting a document was composed 
that summarized the process in a body of statements. All 
participants were offered the opportunity to respond to 
the content and formulation of these statement by e-mail. 
During the final session (Brussels, March 22nd 2017) the 
aim was to compose the present paper as a consensus 
document. These three meetings were then considered 
to be sufficient to meet the Delphi requirements. The 
body of statements was formulated in its final form and 
accepted by all participants. The Executive Committee of 
the ESICM endorsed this consensus by the Cardiovascu-
lar Dynamics Section as an update of a previous consen-
sus published in 2007 [53]. We classified the consensus 
statements as definitions (fact or meaning), requirements 
(a prerequisite or minimum for sufficient quality), and 
recommendations (advice that enhances quality).
Results
Quality assessment of acquired HVM microcirculatory 
images
A prerequisite for assessing the function of the micro-
circulation using HVM imaging is to ensure that arti-
fact-free measurements are made. This is a requirement 
of any monitoring device measuring physiological 
variables, each having its own specific sensitivity to the 
introduction of artifacts. That is why the use of HVM 
measurements requires skill and training (Requirement 
#5, Table 3) similar to other clinical monitoring/diagnos-
tic techniques, such as echocardiography [43]. Although 
not discussed in the consensus meetings as to the precise Ta
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content of a training schedule, it should consist of theo-
retical and practical knowledge about making and ana-
lyzing sublingual microcirculatory imaging as covered 
in the present consensus. Artifacts can be classified 
as pressure artifacts, illumination, focus, content, and 
focus artifacts (uneven focus) (Fig.  2). The main quality 
requirement for an acceptable HVM measurement is that 
single red blood cells can be visualized in the capillaries 
(Requirement #2, Table  3). For this to be accomplished, 
images should be well focused and obtained free of pres-
sure artifacts (Requirement #3, Table 3). Applying exces-
sive pressure to the tissue surface is the most common 
of these artifacts and can lead to the incorrect diagnosis 
of a low flow state. Use of HVM can cause such artifacts 
because the tip of the probe has to make physical contact 
with the tissue surface. As was already recognized in the 
first consensus meeting, pressure artifacts constitute the 
main technical challenge in performing HVM measure-
ments. The presence of such artifacts can be recognized 
as flow being impeded in larger venules (> 20 µm), since it 
is agreed that restricted flow in these large vessels occurs 
mainly because of excessive pressure being applied. Slight 
release of the pressure, and noting the restoration of flow, 
confirms that excessive pressure had been applied during 
the measurement. Other artifacts that must be avoided 
consist of content, focus, and illumination, examples of 
which can be seen in Fig. 2. As a result of the heteroge-
neity of the microcirculation in the sublingual area, it is 
recommended to measure in multiple sites, as well as to 
average the values found during analysis of the different 
areas. An alteration from the previous recommendation 
is to take a minimum of three sublingual areas (previ-
ous recommendation was five) (Recommendation #6, 
Table 3). This is needed because the current HVM gen-
eration has a significantly larger field of view. Addition-
ally, the possibility to make single-spot measurements 
for extended periods of time has been added in order to 
observe changes in single vessels during a therapeutic 
Table 3 Summary of the consensus statements: part 1
RBC red blood cells, TVD total vessel density, PVD perfused vessel density, OPS orthogonal polarization spectral imaging, SDF sidestream dark-field imaging
Image acquisition and quality statements
Definitions
1. Microvessels are defined as vessels with a diameter < 20 µm containing arterioles, capillaries, and venules. Capillaries are defined as vessels < 10 µm 
in diameter where a single file of red blood cells can be observed. The main characteristics of venules include that they are vessels that are collecting 
flow from other vessels and have more RBC filling in the lumen than single RBCs as seen in capillaries
Requirements
2. These should be high‑quality images where RBC can be clearly seen in the capillaries
3. Images should be evenly illuminated, well focused, possess good contrast, and be free of pressure artifacts. Artifacts are defined as absence of flow in 
vessels > 20 µm that returns after release of pressure. An additional characteristic of artifacts is alternating bi/directional flow. A quality score should 
be applied to describe the quality of recording (according to Massey [58]). The quality score should be reported in the article
4. Image sequences should be composed of motion‑free images of at least 4 s (100 frames is the minimum needed to generate space–time frames) but 
ideally should last 20 s in order not to miss intermittent flow. The movement of artifact‑free images can be obtained either by hand or by software 
correction
5. Proper training is required to obtain images of acceptable quality and to perform adequate image analysis. The training and/or experience under‑
gone should be stated when reporting results
Recommendations
6. In the previous consensus, a minimum of 3–5 sites was agreed upon; in this new consensus, we add the possibility of using a single‑spot measure‑
ment during a procedure for evaluating the response of single vessels
7. Measurements of hyperdynamic flow should not be done routinely but restricted to pathophysiological disease states in which hyperdynamic flow 
is anticipated. Hyperdynamic flow is defined as a red blood cell velocity above normal flow in healthy volunteers under resting conditions. Measure‑
ments of hyperdynamic flow should be done quantitatively by space–time frames and not be added to existing semi‑quantitative scores. Measure‑
ments of hyperdynamic flow are physically restricted by the frame rate, according to the following equation:
Vmax = L × f/3 [pm/s], where L is the vessel length in µm, f the frame rate (25 or 30 Hz), and 3 is the number of video frames used for the calculation
8. Unless for specialized application images (specialized locations such as organ surfaces during surgery, cutaneous microcirculation), sublingual meas‑
urements should include a mix of capillaries and venules and, if possible, arterioles. Vessel loops should be avoided as they are considered to be from 
a different anatomical area in the mouth
9. Differences in normal values for vessel density (TVD and PVD) between various optical systems may be up to 30%, depending on resolution, field size, 
and focus, and therefore are not interchangeable in between. These characteristics do not influence variables of red blood cell velocity
10. In the previous recommendation, the use of 5× objectives with OPS and SDF devices was advised for human sublingual microcirculation and a 10× 
objectives for small animals. On the basis of the unavailability of 10× objectives and lack of literature supporting this previous recommendation, we 
abandon this advice and recommend using higher‑magnification objectives
11. In the previous consensus, it was stated that “In larger venules, rolling and adherent leukocytes can be observed, but this requires higher magnifica‑
tion and different analytical methods”. However, with the current technology, leukocytes can be readily seen in the venules, and higher magnification 
is not required
intervention (Recommendation #6, Table 3) [56, 57]. The 
minimum advised recording is 4 s in the current guide-
lines (Recommendation #6, Table  3) [43]. However, we 
suggest to record about 20  s as such time frames can 
contain extra information about microcirculatory kinet-
ics provided a stable recording can be achieved with no 
movement or pressure artifacts. Care should be taken 
when measuring exact red blood cell velocity, espe-
cially during hyperdynamic flow, when the limitation 
of the sampling frequency of the capture card should 
be taken into account (Recommendation #7, Table  3). 
Hyperdynamic flow is a source of controversy as several 
investigators report its presence in critically ill patients, 
while other do not. Since volunteers at rest do not show 
such hyperdynamic flow, its presence can be interpreted 
as a microcirculatory alteration, although its origin and 
clinical meaning still have to be determined. Even though 
its presence can be noted, its quantification can be prob-
lematic because of limitations of the ability of the image 
acquisition to capture the images sufficiently rapidly to 
allow quantification of the velocity of hyperdynamic flow 
(Recommendation #7, Table 3). Caution is required when 
comparing normal values of total vessel density, because 
these can be influenced not only by disease states [26] 
Fig. 2 Conditions of microcirculatory assessment where artifacts can influence the evaluation of the functional state of sublingual microcirculation. 
a Content that can cause an artifact includes saliva and air bubbles obstructing visualization and excessive loops and large venules dominating 
the mix of capillaries flowing into venules required for a representative sublingual microcirculatory network. b Inhomogeneous brightness caused 
by slanted placement of the tip of the HVM to the tissue or an excessive or inadequate amount of illumination can be a cause of artifact. An even 
illumination is advised where all vessels, especially the capillaries, are clearly visible
and ethnicity [33] but, more importantly, by the device 
used. This is because the third-generation IDF devices 
have improved optics with which 30% more vessels can 
be visualized in comparison to the previous-generation 
devices (Recommendation #9, Table 3) [50, 51]. A repre-
sentative mix of vessels including capillaries, venules, and 
possibly arterioles (Recommendation #8, Table 3) should 
be chosen for a measurement, and care should be taken 
to avoid too many vessel loops and venules (Fig.  2a). 
In addition, focus should be adjusted so that single red 
blood cells in the capillaries are visualized, and the field 
of view should be free of artifacts such as excessive saliva 
or bubbles (Fig.  2). This consensus, in contrast to the 
previous consensus, did not see the urgency to develop 
higher-magnification devices, since the improved optics 
currently used are well suited to observe detailed red 
blood cell and leukocytes presence (Recommendations 
#10 and #11, Table  3). However, new as yet unexplored 
subcellular structures such as the glycocalyx or cell-to-
cell junctions could be observed with HVM devices with 
specialized optics. New in this consensus is the require-
ment to have an objective measure (e.g., score) for the 
quality of the image based on the above considerations. 
Such objective quality scores have been developed and 
used in the literature and open the way for an impartial 
evaluation of the quality of the image to be embedded 
in software as a prerequisite for automatic analysis soft-
ware [58–60]. We recommend that an objective quality 
score, such as that described by Massey et al., should be 
reported as part of the methods section in each applica-
ble scientific paper. Its reported interrater agreement (κ) 
on the individual components ranges between 0.71 and 
Fig. 2 continued
1.0, with an overall fail–pass agreement (score > 10 AU) 
of 0.66 [58].
Analysis and interpretation of HVM-recorded sublingual 
microcirculation
The main functional property of the microcirculation 
which needs evaluation in the context of shock and 
resuscitation is its capacity to perfuse the tissues with 
red blood cells that transport oxygen to the tissue cells. 
The two main functional components of the microcir-
culation that describe this physiological function are 
the flow of red blood cells through the capillaries (con-
vective transport of oxygen) and the density of perfused 
capillaries (diffusive transport of oxygen; also referred to 
as functional capillary density) (Definition #12, Table 4). 
Using these two physiological properties of the micro-
circulation, plus the microcirculatory alterations which 
have been observed in states of critical illness (perfu-
sion heterogeneity, specifically in sepsis), several func-
tional microcirculatory measures have been developed, 
as described in the first consensus meeting [53]. On the 
basis of the limitations of the technology and software at 
the time of the first consensus, it was decided that func-
tional measures should be introduced, which could be 
determined without the need for specialized software. 
This requirement led to the development of grid-based 
scoring methods, whereby a grid is drawn on the screen, 
and the properties of vessels intersecting the lines of the 
grid can be quantified (De Backer score [53]) and capil-
lary flow evaluated (microvascular flow index, MFI [61]) 
(Recommendation #13, Table  4). For the assessment of 
the MFI the screen is divided into four quadrants and a 
score between 0 and 3 reflecting the average red blood 
cell velocity is given per quadrant. MFI is then calcu-
lated as the mean MFI averaged over the four quadrants. 
Alternatively, a similar score can be generated by scoring 
all individual vessels on the screen and averaging their 
scores [7, 62], although their precise values may deviate 
from the quadrant-based MFI calculations. Table  4 lists 
these measurements and their properties.
Microcirculatory images can be analyzed by (a) real-
time visual evaluation (“eyeballing”), (b) off-line manual 
analysis (e.g., grid-based or complete screen-based), (c) 
offline software-aided analysis, or (d) online automatic 
analysis (Definition #13, Table  4). Several studies have 
shown that real-time point-of-care (POC) assessment 
by visual inspection of microcirculatory properties at 
the bedside shows good agreement with off-line evalua-
tion of the microcirculation afterwards (Recommenda-
tion #18, Table  4). These instant evaluations have been 
described, as used by nurses [63], and scoring systems 
have been developed and validated for instant evaluation 
of the severity of microcirculatory dysfunction [63–67]. 
These analysis methods are focused mainly on altera-
tions in microcirculatory flow by MFI determination, as 
this value can most easily be evaluated by visual inspec-
tion of the moving microcirculatory images. The POC 
methods for identifying microcirculatory alterations at 
the bedside can form a crucial bridge to the acceptance 
of HVM monitoring as a routine monitor in the clinic, 
pending the development of reliable automatic analysis 
software, since they can potentially provide instant evalu-
ation of the presence of microcirculatory alterations and 
potentially support clinical decisions. However, whether 
such POC use can make a difference to the condition of 
patients will have to be demonstrated in clinical interven-
tion trials.
From these and other studies, MFI values  ≤  2.6 are 
generally agreed upon to identify states of microcir-
culatory alterations (Recommendation #23 Table  4). It 
should be emphasized however that this threshold value 
of 2.6 requires further validation in intervention trials 
with clinical outcomes. In analyzing the flow, it is not 
mandatory to divide the screen into quadrants, as eval-
uation of the complete screen also yields comparable 
information to identify the presence of microcirculatory 
alterations (Recommendation #22, Table  4). For a more 
detailed analysis and to calculate the measures listed in 
Table  5, vessel detection is required. This can either be 
performed manually or can be accomplished by using 
specialized software such as automated vascular analysis 
(AVA), which has been developed for this purpose [68]. 
Although the introduction of AVA software has some-
what eased the methodology of analysis, as grids and 
vessels previously had to be drawn manually, its applica-
tion remains time consuming and is a major limitation to 
the introduction of HVM into routine clinical practice. 
However, with the advancement of technology, several 
attempts have been made to develop automatic software 
capable of analysis for POC use [69–74]. Regardless of 
how promising these developments may be, their use in 
the clinical evaluation of microcirculatory status has yet 
to be validated in clinical practice and cannot be recom-
mended for this purpose presently.
Several measures have been developed and subse-
quently used in the literature to describe the functional 
properties of sublingual microcirculation. These meas-
ures have included variables describing convective flow 
of red blood cells (discussed above) and variables related 
to the diffusion distance of oxygen between the red blood 
cells and the tissue cells. The latter, quantified by the 
functional capillary density (FCD), includes total ves-
sel density (TVD) and perfused vessel density (PVD). 
The minimum dataset required to describe the func-
tional properties of the microcirculation as observed by 
HVM is listed in Table 6. These measures were developed 
primarily for describing microcirculatory alterations 
relating to sepsis and therefore biased towards describing 
the microcirculation under such conditions. The altera-
tions seen in sepsis are often characterized by a highly 
heterogeneous perfusion, with stopped flow capillaries 
next to vessels with flowing cells. To better character-
ize conditions of microcirculatory alteration other than 
those associated with sepsis, the consensus introduced a 
classification which describes the four most seen micro-
circulatory alterations previously observed in various 
clinical scenarios (Definition #15, Table  4) [75]. These 
classifications of microcirculatory alterations serve as 
a methodology to describe the different types of altera-
tions observed by investigators. These types of alterations 
can occur on their own or mixed together, just as differ-
ent pathogenic mechanisms can occur at the same time, 
especially in complex disease states such as sepsis. The 
types of alterations include: Type 1, complete stagnated 
capillaries (circulatory arrest, excessive use of vasopres-
sors); Type 2, reduction in number of flowing capillar-
ies (hemodilution); Type 3, stopped flow vessels are seen 
next to vessels with flowing cells (sepsis, hemorrhage, 
and hemodilution); Type 4, hyperdynamic flow within 
capillaries (hemodilution, sepsis).
Table 4 Summary of the consensus statements: part 2
RBC red blood cell, FCD functional capillary density, PPV proportion of perfused vessels, MFI microcirculatory flow index
Analysis statements
Definitions
12. The main functional variables describing the functional state of the microcirculation are related to their oxygen‑carrying capacity, defined by a 
measure of convective flow (RBC flow), diffusive capacity (FCD), and oxygenation
13. Analysis of images can be achieved by (a) real‑time visual evaluation, (b) off‑line manual analysis (grid‑based), (c) off‑line software‑aided analysis, 
and (d) on‑line automatic analysis. It should be made clear which type of evaluation was used, and reference should be made to validation studies of 
the chosen analysis methodology
14. Space–time diagrams (STDs) are the gold standard for quantitative measurements of RBC velocity. It should be noted that not all microvessels con‑
tain the physical characteristics (clear visualization of particular nature of the RBCs) that make them suitable for STD analysis, creating potential bias in 
the analysis
15. Alterations in the sublingual microcirculation have previously been used mainly to describe changes observed in patients associated with sepsis. 
However, because currently other disease states are also being investigated, a differential diagnosis of the type of alterations is required. Such differ‑
ent types of microcirculatory alterations can be classified as follows:
 Type 1: complete stagnated capillaries (circulatory arrest, excessive use of vasopressors)
 Type 2: reduction in number of flowing capillaries (hemodilution)
 Type 3: plugged vessels are seen next to vessels with flowing cells (sepsis, hemorrhage, and hemodilution)
 Type 4: hyperdynamic flow within of capillaries (hemodilution, exercise, sepsis)
16. In the previous consensus, reference was made only to video recordings. Now, with advancement in technology, image sensors allow the rapid 
capture of still images to be made and played back at video speed
Recommendations
17. Surrogates for functional variables can be used in cases where RBC velocity is measured as a semi‑quantitative index or preferably quantitative value 
is used. Previously, grid‑based scoring methods have been used for scoring, and these have been shown to discriminate between health and disease 
states
18. Grid‑based scoring systems do not provide quantitative values of velocity but can be used for point‑of‑care assessment of the presence or absence 
of microcirculatory alterations. Such assessment is valuable to distinguish patients with a normal microcirculation from patients with an abnormal 
microcirculation and to characterize a type of shock
19. Space–time frames analysis should be applied when quantitative variation in RBC distinction needs to be made between different levels of veloci‑
ties (in heart failure or during stepwise flow reduction on cardiopulmonary bypass or assist devices)
20. Previous recommendations stated that “large external monitors should be used instead of the liquid crystal display (LCD) screen of the computer”. 
With the improved high definition (HD) screens currently available, this is no longer required
21. Heterogeneity of blood flow is a hallmark of distributive shock and thus a vital variable to determine the type of shock. Under such circumstances a 
coefficient of variation between a variable within different areas of interest should be provided to quantify this heterogeneity. Ideally, future software 
analysis should be able to provide a heterogeneity index based on the red blood cell velocity distribution in between individual vessels
22. In the previous consensus, it was stated that “Separation of the screen into quadrants (or using equidistant lines) is mandatory when analysis is done 
by eye.” However, several studies have demonstrated that microcirculatory alterations can be identified by “eyeballing” without the need to perform a 
quadrant analysis. This only is applicable to point‑of‑care assessment and not to quantification
23. As of now, data on the clinical relevance of microvascular alterations are predominantly expressed in PPV and MFI. Although cutoff values for a 
normal MFI are > 2.9, cutoff values for MFI of 2.6 are suggested as a threshold below which alterations can be considered clinically relevant
24. Clips should be de‑identified and randomized before analysis to minimize bias
25. Microcirculatory measurements using intravital microscopy in adult humans are currently also applied to other locations than the sublingual area. 
For other regions, children‑ and animal‑specific criteria for good measurement and analysis should be developed and validated
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The minimum dataset necessary for distinguishing 
between the various states of microcirculatory altera-
tions is listed in Table  6. Extensive literature has been 
published related to the effect of various pharmacologi-
cal therapies on the microcirculation, as seen in states 
of shock including fluids [45, 46, 76–78], blood [79–82], 
vasoactive medication [4, 47–49, 83, 84], anesthesia [85, 
86], and mechanical support therapies such as extracor-
poreal membrane oxygenation (ECMO) [6, 87–90], car-
diopulmonary bypass (CPB) [91–93], and intra-aortic 
balloon pulsation (IABP) [94–96]. Table  7 lists which 
measures need to be assessed in order to demonstrate the 
efficacy of therapeutic interventions aimed at resuscitat-
ing the microcirculation. In addition to such evaluation 
of measures, intravenous fluids [77] or vasoactive chal-
lenge [83, 97] has been used to identify the microvascular 
reactivity and/or reserve (Table 8). 
Although qualitative evaluation has been extensively 
used in the literature, quantitative evaluation of micro-
circulatory flow is required for a more precise charac-
terization of other types of flow alterations than those 
occurring in sepsis, which also allows for a more pre-
cise description of the amount of heterogeneity pre-
sent than the scoring methodology currently used [10]. 
A practical example is a slower flow associated with 
heart failure, which can be readily observed but which 
may be inaptly described by the qualitative flow meas-
ures currently available. On the basis of the perception 
that simply giving numerical values to microcirculatory 
flow patterns insufficiently describes the complex 
flow patterns seen in microcirculatory images, the so-
called space–time diagrams (STDs) were developed to 
describe quantitative red blood cell velocity profiles [98] 
(Fig.  3). These STDs have been used in several HVM 
studies for quantitative evaluation and identification of 
abnormal blood flow patterns [7, 93]. The potential to 
create STDs is embedded in AVA [68] and can also be 
generated automatically using computer-controlled IDF 
imaging [72].
From these considerations, it is clear that new auto-
matic software analysis is a key requirement for the 
improvement of HVM. Technological advances includ-
ing computer-controlled HVM, where illumination and 
image capturing are synchronized, will allow automatic 
software to be developed more readily. Within the soft-
ware, quality analysis of the images, image stabiliza-
tion, and quantitative recognition analysis will need to 
be present. Since other applications for HVM analysis 
of the sublingual microcirculation are being developed, 
such as in infants [27] and in various organs with multi-
ple morphologies and states of disease [14–16, 99, 100], 
future software must be flexible to incorporate these. 
This would open up the possibility to extend its use to 
other disease states and therapies, where monitoring the 
hemodynamics, cellular constituents, or morphology of 
the microcirculation would be relevant for understanding 
the underlying pathophysiology or the response to ther-
apy (Recommendation #25, Table 4).
Table 6 Minimum dataset of microvascular variables per type of shock
MFIquadrant microvascular flow index per quadrant, MFIvessel microvascular flow index per vessel, NA not applicable
Type of shock Variables of convective blood flow Variables of diffusive capacity Variables of heterogeneity Vessel type
Hemorrhagic 1.  MFIquadrant/MFIvessel AND 1. Total vessel density NA Capillaries
OR
2. Percentage of perfused 
vessels
2. De Backer score NA Capillaries
Cardiogenic 1.  MFIquadrant/MFIvessel AND 1. Total vessel density NA Capillaries
OR
2. Percentage of perfused 
vessels
AND 2. De Backer score NA Capillaries
Distributive 1.  MFIquadrant/MFIvessel AND Total vessel density plus per‑
fused vessel density
AND Heterogeneity index Capillaries & venules
OR
2. Percentage of perfused 
vessels
AND De Backer score AND Heterogeneity index Capillaries & venules
Obstructive 1.  MFIquadrant/MFIvessel AND Total vessel density plus per‑
fused vessel density
NA Capillaries
OR
2. Percentage of perfused 
vessels
AND De Backer score NA Capillaries
Future developments and horizons
The next phase in the clinical development of HVM 
for bedside monitoring of the microcirculation is to 
integrate it into routine clinical practice (Recommen-
dation #29, Table  9) [101]. The mention of microcircu-
latory monitoring in the consensus on circulatory shock 
and hemodynamic monitoring of the task force for the 
ESICM in 2014 [54], as part of the arsenal of hemody-
namic monitors which can be used for shock monitor-
ing, indicates an acceptance that HVM has acquired a 
role in the cardiovascular monitoring for the critically 
ill. Despite the many publications and the application 
of microcirculatory monitoring using HVM in numer-
ous clinical and experimental scenarios, along with the 
recent important technical developments that have been 
achieved in this field, further developments are needed 
prior to its integration into routine clinical practice. 
In this context it will be imperative to conduct trials 
whereby microcirculatory alterations are identified by 
HVM and corrected by specific interventions that lead 
to clinically relevant benefit for the patient (Recommen-
dation #39, Table 9).
Table 7 Minimum dataset per type of microvascular abnormality
MFIquadrant microvascular flow index per quadrant, MFIvessel microvascular flow index per vessel, NA not applicable
Type of microvascular 
abnormality
Variables of convective blood 
flow
Variables of diffusive capacity Variables of heteroge-
neity
Vessel type
Type 1. Completely stag‑
nated capillaries (circula‑
tory arrest, excessive use 
of vasopressors)
1.  MFIquadrant/MFIvessel NA NA Capillaries
OR
2. Percentage of perfused 
vessels
NA NA Capillaries
Type 2. Reduction in num‑
ber of flowing capillaries 
(hemodilution)
NA (Optional: space–time 
frame to quantify hyper‑
dynamic flow)
1. Total vessel density NA Capillaries
OR
2. De Backer score NA Capillaries
Type 3. Plugged vessels 
are seen next to vessels 
with flowing red blood 
cells (sepsis, hemor‑
rhage)
1.  MFIquadrant/MFIvessel AND Total vessel density plus 
perfused vessel density
AND Heterogeneity index Capillaries & venules
OR
2. Percentage of perfused 
vessels
AND De Backer score AND Heterogeneity index Capillaries & venules
Type 4. Hyperdynamic 
flow within of capillaries 
(hemodilution, exercise, 
sepsis)
Space–time  framesvessel NA NA Capillaries
Table 8 Minimum dataset for the evaluation of the change in microvascular variables per intervention
MFIquadrant microvascular flow index per quadrant, MFIvessel microvascular flow index per vessel, NA not applicable, ECMO extracorporeal membrane oxygenation, IABP 
intra-aortic balloon pump
Type of microvascular 
shock
Variables of convective blood 
flow
Variables of diffusive capacity Variables of heteroge-
neity
Vessel type
Fluid administration 1.  MFIquadrant/MFIvessel AND Total vessel density plus 
perfused vessel density
NA Capillaries & venules
OR
2. Percentage of perfused 
vessels
AND De Backer score NA Capillaries & venules
Vasopressor administration 1.  MFIquadrant/MFIvessel AND Total vessel density plus 
perfused vessel density
AND Heterogeneity index Capillaries
OR
2. Percentage of perfused 
vessels
AND De Backer score AND Heterogeneity index Capillaries
Weaning from ECMO or 
IABP
1.  MFIquadrant/MFIvessel AND Total vessel density plus 
perfused vessel density
NA Capillaries
OR
2. Percentage of perfused 
vessels
AND De Backer score NA Capillaries
The two foremost developments that are required are 
firstly ease of image acquisition, so that rapid artifact-free 
images can be obtained promptly, and secondly that the 
analysis of the images and classifications of the type of 
alterations present should be done rapidly, reliably, and 
automatically. Concerning this last point, it is advised 
that new, more physiologically based microcirculatory 
variables are introduced because they relate more directly 
to the function of the microcirculation which is to trans-
port oxygen to the tissues. With the recent develop-
ment of computer-controlled image sensor-based HVM 
systems and several automatic microcirculatory analy-
sis software systems in progress, it is envisaged that 
physiologically based microcirculatory variables will be 
Fig. 3 Space–time diagrams (STD). a STD of a specified length of capillary vessel is generated by specialized software. The arrow indicates the direc‑
tion of red blood cell (RBC) flow. The line L is drawn of length d, where the entry point to the capillary is defined as L = 0. b The STD of this vessel 
in a is drawn whereby the y axis represents the length of the blood vessel segment L, with at the top of the y axis the entrance of the vessel (L = 0) 
and at the bottom of the y axis the length d of the blood vessel. On the x axis is time. The STD is then generated by each red blood cell entering the 
blood vessel at L = 0 and exiting the diagram at L = d. In this way each moving red blood cell generates a line, the slope of which equals the veloc‑
ity (velocity = ∆L/∆t). c Example of an STD with the pulsatile kinetics of capillary flow under normal conditions of a patient prior to cardiac surgery. 
d STD of the same patient as in c now with laminar capillary flow during non‑pulsatile pump support during cardiac surgery (c and d reproduced 
with permission from [93])
introduced in the near future. Analysis of these images 
would directly relate to the physiological function of the 
microcirculation, which is to transport oxygen to the tis-
sues (Recommendation #30, Table  9). These measures 
were defined early on in intravital microscopy investiga-
tions as relating to the oxygen-transporting capacity of 
the microcirculation in muscle by capillary hematocrit 
[102]. The main functional variables describing the con-
vective capacity of the capillaries of the microcirculation 
to transport oxygen are the tube hematocrit (the hema-
tocrit of the blood in a capillary at a moment in time) 
and the discharge hematocrit (the hematocrit flowing 
through the capillaries per unit of time). The diffusive 
capacity of the microcirculation is described by the FCD 
(Recommendation #30, Table  9). When developing the 
next generation of automatic analysis software, trans-
parency of algorithms and the ability to measure sub-
sets of microcirculatory variables are of vital importance 
(Requirement #26 and Recommendation #37, Table  9) 
[103]. When applying such functional analysis software, 
it will be important to establish normal values in differ-
ent age populations [24], and specifically in the develop-
mental stages from the neonates on through childhood 
(Recommendation #32, Table  9) [25]. Following such a 
description, critical microcirculatory values should be 
identified, below which pathophysiology is identified 
(Recommendation #31, Table 9).
An additional variable of interest would be to include 
the hemoglobin saturation of the red blood cells in the 
field of view in order to complete the description of the 
oxygen-transporting capacity of the microcirculation. 
Such measurements have been used in intravital micros-
copy to investigate oxygen transport in experimental 
animals [104]. Indeed, such a variable could quite easily 
be incorporated in HVM by the inclusion of differently 
colored LEDs [105]. Such a future HVM spectropho-
tometry method, with the physiological variables pro-
posed, would indeed be a major development in HVM. 
Table 9 Summary of the consensus statements: part 3
RBC red blood cells, CapHt capillary hematocrit
Future perspectives
Requirements
26. Development of future automatic analysis must be transparent in terms of published algorithms and validated in experimental and clinical settings
27. Automatic algorithms should always allow the user to edit automatically detected vessels and allow analysis of a subset of vessels
28. Automatic algorithms should provide the user information concerning the quality of measurement prior to automatically analyzing the image
Recommendations
29. It is recommended to pursue the objective of inclusion of microcirculatory assessment as part of routine hemodynamic assessment at the bedside
30. Functional measures should be expanded to include the oxygen‑transporting capacity of the blood flow in the microcirculation. In doing so, 
the capillary RBC count should be expanded to include measures related to microcirculatory oxygen‑delivering capacity with capillary hematocrit 
(volume of RBC/volume of capillary) and discharge hematocrit (CapHt/unit time), functional capillary density as well as its oxygen‑carrying capacity. 
To this end, RBC counts will have to be introduced and integrated along with vessel diameters. Velocity measurements should be quantitative and 
replaced by flow measurements as well as the oxygen‑transporting capacity of the microcirculation. In doing so, a measure of heterogeneity, whether 
physiological or pathophysiological, should be added
31. Reference values should be identified for the various microcirculatory variables below which microcirculatory alterations are defined as persisting. It 
is expected that such reference values will define microcirculation‑guided resuscitation end points
32. For the pediatric age group, development of normalized values from birth until adolescence is essential as background comparative data
33. Microcirculatory measurements should be integrated with macrocirculatory measurements to provide a comprehensive hemodynamic picture and 
evaluate the presence or absence of regulatory mechanisms responsible for hemodynamic coherence between the different levels of the circulation. 
Note: This is of significance because the presence of hemodynamic coherence indicates that hemodynamic regulatory mechanisms are intact during 
resuscitation and that targeting the systemic circulation is an adequate resuscitation strategy
34. The previous consensus stated that “The ideal software, we propose, should automatically recognize all blood vessels and measure their diameters 
and blood flow in each individual vessel of the investigated field. This is not currently available.” Unfortunately, such a solution is not yet available, 
although several software packages have been released but not yet validated. Analysis software calculating physiological variables related to macro‑
circulatory oxygen delivery is still wanting
35. Tools should be developed to make pressure‑artifact‑free measurements and allow single‑spot measurements to be made during a therapeutic 
maneuver
36. Leukocyte tracking and kinetics should be measured and related to activation of inflammatory pathways. Platelet identification is helpful to address 
the interplay between inflammation and coagulation
37. Technology should be developed to allow stable measurements to be made for longer periods of time to allow continuous measurement during, 
for example, a therapeutic maneuver allowing observation of the response of single vessels before and after the intervention
38. Optical magnification increases should be possible to identify cellular and subcellular structures (glycocalyx, cell‑to‑cell connections)
39. It is recommended that trials be undertaken whereby microcirculatory alterations are identified by HVM and corrected by specific interventions that 
lead to clinically relevant benefit for the patient
Consequently, it would allow integration in systemic 
hemodynamic variables for a comprehensive description 
of the oxygen-transporting capacity of the cardiovascular 
system at the bedside. In addition, a more comprehensive 
measure of heterogeneity could be incorporated which 
is based on the distribution of flow, thereby allowing a 
better description of the physiological function of the 
microcirculation to be accomplished in combination with 
morphometric analysis.
There is also a need for further development of the 
hardware in order to more readily and reliably perform 
HVM at the bedside. In this respect, hardware develop-
ment that allows measurements to be made instantly 
and without pressure artifacts would greatly facilitate 
the introduction of HVM into routine use at the bedside. 
Future developments allowing hands-free measurements 
to be made, so that measurements can be made in one 
and the same location for extended periods of time (Rec-
ommendation #37, Table  9) during therapeutic maneu-
vers, would allow a much more precise evaluation of the 
functional state of the microcirculation. Finally, it is con-
ceivable that developments in the optics of HVM systems 
could allow for much more detailed observations of cel-
lular and even intracellular structures [106].
The main near-future development for HVM in clini-
cal practice will be its integration with macrohemody-
namic measurements, thus providing an integrative and 
functional evaluation of the cardiovascular system from 
the heart to the capillaries [107, 108]. In doing so changes 
in microcirculatory properties in the different phases 
of life will need to be taken into account alongside the 
effects of chronic disease states. For the pediatric popu-
lation longitudinal data are warranted from the “nor-
mal” extremely low birth weight infant till adolescence as 
significant changes have been identified to occur in the 
first week of life [29]. Furthermore, identifying the pres-
ence or absence of hemodynamic coherence between 
the different compartments of the cardiovascular system 
may become possible (Recommendation #33, Table  9). 
Although microcirculatory monitoring has improved, 
training in its use, both in terms of performing the meas-
urements as well as interpreting the images, is necessary. 
A comprehensive knowledge of the functional behavior 
of the microcirculation and its cellular components in 
health and disease will also be essential.
Finally some shortcomings of this consensus need 
to be mentioned. The use of the Delphi method can be 
questioned as an appropriate format to reach a consen-
sus and indeed several other methodologies have been 
put forward to define a consensus [109, 110]. We chose 
the Delphi method because a previous similar consen-
sus reached from the Cardiovascular Dynamics Section 
of the ESICM had used the same methodology [54]. In 
addition, these other methodologies included criteria 
which were much better suited for more conventional 
guidelines and devices such as financial considerations, 
issues we felt were not relevant for our subject matter. A 
second shortcoming of our consensus is the absence of 
the availability of more advanced software for analysis of 
microcirculatory images. Although some initial versions 
are currently available they require validation and further 
development by the field.
Conclusion
In this paper we provided a set of guidelines on micro-
circulatory imaging, using hand-held microscopy at the 
bedside. We expect that this consensus paper, created 
by the Cardiovascular Dynamics Section of the ESICM 
and endorsed by its Executive Committee, will make an 
important contribution to the current and future use of 
HVM in critically ill patients.
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